Several biomarkers such as S100β [14], [15], glial fibrillary acidic protein (GFAP) [16], [17], matrix metalloproteinase-9 (MMP-9) [18], [19], and neuron-specific enolase (NSE) [20], [21] have been extensively studied in stroke. This evidence concerns the gene GFAP and stroke disorder.